Alligator Bioscience Stock (OTCMKTS:ALLGF)

USA |OTCGREY |USD

Price
$ -
Change
-
Today's Range
$ - - $ -
52-Week Range
$ 0.87 - $ 0.87
Market Cap
$ -
Volume
-

About Alligator Bioscience (OTCMKTS:ALLGF)

(OTCMKTS:ALLGF) Alligator Bioscience AB (publ) develops antibody-based pharmaceuticals for cancer treatment. It develops products using its technology platforms, including ALLIGATOR-GOLD, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and bispecific antibody formats for the development of novel dual-action antibodies. The company develops ADC-1013, an immunostimulatory CD40 antibody, which has completed Phase I clinical trial for the treatment of metastatic cancer; ATOR-1015, a tumor-localizing bispecific CTLA-4 and OX40 antibody, which is in Phase I clinical trial for tumor-directed treatment of metastatic cancer; and ATOR-1017, an immunostimulatory antibody, which is in phase I clinical trial that binds to the receptor 4-1BB (CD137) in tumor-specific T cells. Its drug candidates in the preclinical development stage include ALG.APV-527, a bispecific 4-1BB and 5T4 antibody for the treatment of metastatic cancer; and ATOR-1144, a bispecific antibody to treat solid tumors and hematologic cancers. The company, through its subsidiary, Atlas Therapeutics AB, also holds a stake in clinical project Biosynergy (AC101), which is in phase I clinical trial. It has operations in the United States, Sweden, Asia, and internationally. The company has a partnership agreement with Aptevo Therapeutics Inc. for the co-development of ALG.APV-527. Alligator Bioscience AB (publ) was founded in 2001 and is headquartered in Lund, Sweden.
Show more

ALLGF Stock Price

Statistics Highlights (OTCMKTS:ALLGF)

Shares Outstanding - Beta 1.02
Public Float 53.02M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 15.23% Ex-Dividend Date
Held by Institutions 18.85% IPO Date -

ALLGF Financial Summary

|
Dec 19 Dec 18 Dec 17
Revenue $4.36M $27.03M $56.88M
EBITDA $ $ $
Net Income $-210.11M $-150.04M $-63.76M
Total Assets $311.13M $508.16M $643.03M
Total Cash $196.87M $362.88M $472.92M
Total Debt $ $ $
Sep 20 Jun 20 Mar 20
Revenue $ $ $
EBITDA $ $ $
Net Income $ $ $
Total Assets $ $ $
Total Cash $ $ $
Total Debt $ $ $

(OTCMKTS:ALLGF) Stock Price FAQs

What is Alligator Bioscience's 52-week change?

  • Alligator Bioscience share price volatility (52-week beta) is 1.02.

Alligator Bioscience (OTCMKTS:ALLGF) FAQ

How Much is Alligator bioscience Worth?

Alligator bioscience's worth today based on market capitalisation is $

How much dividend does Alligator bioscience Pay?

The current annualized dividend payout for ALLGF stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Alligator bioscience's "Dividend" Section

What is Alligator bioscience’s Price to Earning (PE) ratio?

ALLGF stock also has a Price to Sales (P/S) ratio of 0.00.

What is the Alligator bioscience's ticker?

Alligator bioscience trades on the OTC Markets stock market in USA under the ticker symbol "ALLGF". Alligator bioscience’s stock symbol can also be displayed as "OTCMKTS:ALLGF".

Who are the owners of Alligator bioscience?

Alligator bioscience (OTCMKTS:ALLGF) is owned by 18.85% institutional shareholders and by 15.23% insiders. The rest is owned by the public.
Explore More Details on Alligator bioscience's “Ownership” Section

Who are the key executives of Alligator bioscience (ALLGF)?

Alligator bioscience's key executive team includes the following managers:

  • Dr. Per Norlén, Chief Exec. Officer (1970)
  • Ms. Marie Svensson, Chief Financial Officer (1964)
  • Dr. Malin Carlsson, Head of R&D, Exec. VP & COO (1968)
  • Dr. Peter Ellmark Ph.D., Chief Scientific Officer (1973)
  • Ms. Cecilia Hofvander, Director of Investor Relations & Communications (1967)
  • Dr. Christina Furebring, Sr. VP of Projects (1964)
  • Ms. Gayle M. Mills, Chief Bus. Officer (1955)
  • Dr. Christina Reimer, Chief Medical Officer (NA)

What is Alligator bioscience’s Sector & Industry Classification?

Alligator bioscience (OTCMKTS:ALLGF) is classified under the "" sector and under the "" industry.

How many employees work for Alligator bioscience?

Currently the number of employees working for Alligator bioscience is 46.

Where are Alligator bioscience's Headquarters?

Alligator bioscience (OTCMKTS:ALLGF) is headquartered in Sweden.

What are Alligator bioscience's Address and Phone Number?

Alligator bioscience’s mailing address is Medicon Village, Lund, Sweden, 223 81.
The company’s phone number is 46 4 65 40 82 00.

What is the official website for Alligator bioscience?

Alligator bioscience’s official website is http://www.alligatorbioscience.se